Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is well-positioned for growth in the coming years with its strong portfolio of hospitals, ambulatory surgery centers, and revenue cycle management solutions. The company's continued investment in high-end services such as robotic surgery, coupled with its cost control and efficiency improvements, should lead to increased profitability. This, along with its reasonable leverage ratio and strong cash flow, supports Tenet's positive outlook.

Bears say

Tenet Healthcare is facing a challenging sentiment apparatus for hospitals and broader healthcare services, leading to a decrease in its price target. While the company has shown strong expense management and FCF generation, low enrollment in healthcare plans and a decline in hospital length of stay are causing headwinds. However, the company's cost-efficiency and process automation initiatives may help offset these challenges in the future.

Tenet Healthcare (THC) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 17 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $265.35, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $265.35, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.